surmount-1 trial tirzepatide obesity without diabetes weight loss for the Maintenance of Body Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - SURMOUNT Clinical Trials Orals Session

Frequently Asked Questions Will I regain all my weight after stopping semaglutide

A plateau generally refers to minimal weight change over 4-6 weeks at a stable dose with confirmed adherence

Frequently Asked Questions What are tirzepatide and semaglutide used for

Potential Benefits of Tirzepatide The potential benefits of Tirzepatide are substantial and have garnered attention for their impact on weight management and overall health: Significant Weight Loss: According to clinical trials, people using Tirzepatide can lose an impressive amount of weightoften more than 10%of their starting weight

ATTAIN Phase 3 trials show a manageable GLP-1-class side effect profile No unexpected serious safety signals have emerged in published data to date Hypoglycaemia risk is low when used without insulin or sulphonylureas Long-term cardiovascular outcomes data is still being collected Regulatory review by bodies including the MHRA is ongoing as of 2026 Orforglipron Side Effects: What to Expect Understanding side effects is central to any honest safety discussion